Carillion PLC
01 November 2007
Carillion wins building contracts worth £137 million for public and private
sector customers
Support services and construction company Carillion has won three new contracts
in the UK worth approximately £137 million: a £70 million contract for the new
Rolls Building in London, two contracts for the Scottish Prison Service in
Edinburgh worth some £47 million and a contract to provide new offices for the
Welsh Assembly Government in Aberystwyth with a target cost of approximately £20
million.
The new eleven storey Rolls Building in Fetter Lane, will provide new office
accommodation to replace the existing Rolls House, Arnold House and No 8 Bream
Buildings for development manager Delancey Estates. The development is a joint
venture on behalf of funds advised by Delancey and Invista Real Estate
Investment Management and is due for completion in October 2009.
The £20 million contract for the Welsh Assembly Government will provide new
multifunctional offices to accommodate up to 535 staff. The building will
provide predominantly naturally ventilated open plan office space, heating from
biomass boilers, rainwater harvesting, solar panels for hot water, and overall
achieves an excellent BREEAM rating.
The contracts for the Scottish Prison Service (SPS), which have been awarded
under a framework agreement with the SPS, involve the design and construction of
a new 135-prisoner place house block at HMP Edinburgh and a new gate complex,
kitchen, energy centre, prisoner reception, games hall and health centre for HM
Young Offenders Institution Polmont at Falkirk.
Commenting, Carillion Chief Executive, John McDonough, said: 'In line with our
strategy of focusing on high quality projects for key customers we are delighted
to have been appointed as the delivery partner with Delancey and Invista for the
prestigious Rolls Building project in the City of London and to have won further
contracts for the Scottish Prison Service and for the Welsh Assembly Government.
'The contracts for the Rolls Building and Welsh Assembly Government were won
using the two stage tender process, consistent with our strategy of growing
construction margins ahead of revenue through applying our rigorous project
selectivity and risk management criteria.
'The contracts for HM Prison Edinburgh and HM Young Offenders Institution
Polmont were awarded under our long-term framework contract with the Scottish
Prison Service and we look forward to working closely with the SPS to deliver
these new projects, which form part of its ongoing programme to improve prisons
in Scotland.'
Notes to Editors
History of the Rolls Building
The current Rolls House was built in the 1960s to replace Geraldine House, which
was once the offices and printing house for the Daily Mirror. The use of the
name 'Rolls' comes from the 'Rolls House' having been situated at this location,
before becoming later known as the Public Records Office.
Carillion is one of the UK's leading support services, construction and Public
Private Partnership project companies. The Group has annual revenue of around
£4bn, employs over 40,000 people and operates across the UK, in the Middle East,
Canada and the Caribbean.
In the UK, Carillion has eight principal market sectors - Defence, Education,
Health, Building, Facilities Management and Services, Roads, Rail and Civil
Engineering. In the Middle East, the Group's two principal market sectors are
Construction and Facilities Management whilst in Canada and the Caribbean they
are Health, Roads Maintenance and Construction.
The Group is a leader in Public Private Partnership projects, particularly in
the Defence, Education and Health sectors in the UK and in the Health sector in
Canada.
This and other news releases relating to the Group can be found at
www.carillionplc.com
For further information:
John Denning, Director Group Corporate Affairs, Carillion plc 01902 316426
This information is provided by RNS
The company news service from the London Stock Exchange
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.